Significant Ownership of PFIZER INC

Manager identity
Signature and title
/s/ Madelyn D. Purcell - Madelyn D. Purcell/Assistant Secretary
Location
New York, NY
Large-stake snapshot
Schedule 13D/G summary
Recent SEC Schedule 13D/G filings for PFIZER INC, focused on large-stake beneficial ownership disclosures and amendments.

Follow Filing Activity

Follow PFIZER INC and return when a new Schedule 13D/G filing changes the record on this page.

This uses the existing product follow flow to surface future filing-backed changes without guessing what they mean. If you create an account from here, we will bring you back after verification.

Create free account and return here Already have an account? Sign in and return here

Significant Ownership of PFIZER INC

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ALLO Allogene Therapeutics, Inc. Common Stock, par value $0.001 per share (the "Common Stock") 9% $30,183,895 22,032,040 Pfizer Inc. 06 Nov 2025
ZURA Zura Bio Limited Class A Ordinary Shares, $0.0001 par value per share 4.6% $4,276,832 2,970,022 Pfizer Inc. 13-5315170 31 Dec 2024
CRDF Cardiff Oncology, Inc. Common Stock, $0.0001 par value per share 3.6% $6,704,178 2,411,575 Pfizer Inc. 13-5315170 31 Dec 2024
ORIC ORIC Pharmaceuticals, Inc. Common Stock par value $0.0001 per share 3.3% $35,806,576 3,442,940 Pfizer Inc. (IRS Identification No.: 13-5315170) 31 Mar 2026
NXTC NEXTCURE, INC. Common Stock par value $0.001 per share 3% $923,806 157,646 Pfizer Inc. (IRS Identification No.: 13-5315170) 31 Dec 2025
QTTB Q32 Bio Inc. Common Stock par value $0.0001 per share 2.3% $994,442 277,777 Pfizer Inc. (IRS Identification No.: 13-5315170) 31 Dec 2024
HLN Haleon plc Ordinary Shares, nominal value GBP0.01 per share 0% $0 -$6,822,227,667 0 -100% Pfizer Inc. 21 Mar 2025

Schedules 13D/G Reported by PFIZER INC:

Sym Target Class Ownership Change Current shares Change Value Reporting name Form Report period Filing date
Schedule rows are parsed from SEC 13D/G filings. Open the linked filing or target page to verify the reported ownership and shares.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .